Skip to main content

Table 2 I.p. application of trAb anti-EpCAM and side effects

From: Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis

Pat.

TrAb anti-EpCAM therapy (μg i.p./day)

Cumulative dose

Side effects

 

μg

day

μg

day

μg

day

(μg)

 

A

10

1

20

5

20

9

50

Elev. of AP (3), γ-GT (4); fever (3); abdominal pain (3); vomiting (3)

B

10

1

20

6

40

9

70

Elev. of AP (2), bilirubin (2), γ-GT (3), GOT (3), GPT (3); fever (3); abd. pain (3); vomiting (2); allergic exanthema (2)

C

5

1

20

3

40

7

65

Fever (2)

F

10

1

20

5

-

 

30

Elev. of AP (2), PTT (2), GPT (3); fever (1); abdominal pain (3); vomiting (2)

G

10

1

20

5

40

10

70

Elev. of AP (1), bilirubin (2), γ-GT (3), GPT (3); fever (1); abdominal pain (3)

H

10

1

20

7

40

13

70

Elev. of AP (1), bilirubin (2), gGT (3), creatinine (2); fever (1); abdominal pain (3)

I

10

1

20

8

40

12

70

Elev. of AP (1); fever (2); vomiting (3)